(2E)-3-(2,5-dimethoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

TRANS-2-(PYRIDIN-4-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 200mg

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,10 µm, 1 Stück

4-(3-Methoxyphenyl)-1H-pyrazole, 250mg

2,4-Dibromoanisole>98.0%(GC)25g

METHYL 3-((2-AMINO-5-FLUOROBENZYL)OXY)-4-BROMOBENZOATE, 95.0%, 250mg

3-Bromo-1H-indazole-5-carbonitrile, 95.0%, 25g

2-Amino-6-chloropyrido[3,2-d]pyrimidin-4(1H)-one, 95.0%, 100mg

Methyl 3-amino-4-(trifluoromethoxy)benzoate, 97%, 5g

6-BROMO-2,4-DICHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 500mg

N-(4-Methyl-3-nitrophenyl)-3-(trifluoromethyl)benzamide, 95%, 1g

(Z)-4,4,5,5-Tetramethyl-2-(prop-1-en-1-yl)-1,3,2-dioxaborolane, 95% mix TBC as stabilizer, 10g

3-(2-Methoxyphenyl)propan-1-ol, 95.0%, 10g